Novartis Ag (NVS) Divestments (2011 - 2026)
Novartis Ag (NVS) posted Divestments of -$2.0 million for Q1 2026, up 77.78% sequentially from -$9.0 million in Q4 2025, and up 50.0% YoY from -$1.3 million in Q1 2025.
Novartis Ag (NVS) Divestments (2011 - 2026) Analysis & Trends
Novartis Ag (NVS) has 14 years of Divestments data on file, last reported at -$2.0 million in Q1 2026.
- Quarterly Divestments rose 50.0% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$213.0 million (up 93.24% YoY) and the FY2025 annual result came in at -$88.0 million, down 182.24% from the prior year.
- Divestments rose to -$2.0 million in Q1 2026 per NVS's latest filing, from -$9.0 million in the prior quarter.
- The five-year high for Divestments was $164.0 million in Q4 2024, with the low at -$3.3 billion in Q2 2024.
- Average Divestments over 5 years is -$285.1 million, with a median of -$23.0 million recorded in 2023.
- The widest YoY moves for Divestments: up 2150.0% in 2024, down 3851.19% in 2024.
- Novartis Ag's Divestments stood at -$7.0 million in 2022, then slipped by 14.29% to -$8.0 million in 2023, then jumped by 2150.0% to $164.0 million in 2024, then tumbled by 105.49% to -$9.0 million in 2025, then surged by 77.78% to -$2.0 million in 2026.
- Business Quant data shows NVS's Divestments at -$2.0 million in Q1 2026, -$9.0 million in Q4 2025, and -$64.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -2.00 Mn |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | -9.00 Mn |
| Sep 30, 2025 | -64.00 Mn |
| Jun 30, 2025 | -138.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | 164.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | -3.32 Bn |
| Mar 31, 2024 | -279.00 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Sep 30, 2023 | -208.00 Mn |
| Jun 30, 2023 | -84.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -7.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | -59.00 Mn |
| Mar 31, 2022 | -821.00 Mn |
| Dec 31, 2021 | -343.00 Mn |
| Sep 30, 2021 | -15.00 Mn |
| Mar 31, 2021 | -209.00 Mn |